HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet
— First randomized Phase III trial confirming the efficacy of MET inhibition…
HUTCHMED Highlights Pipeline and Business Progress at R&D Updates Event
November 02, 2025 19:00 ET | Source: HUTCHMED (China) Limited — HUTCHMED…
Save the Date: HUTCHMED to Present R&D Updates on October 31, 2025
— HUTCHMED will host in-person presentation and online webinar on Friday, October…
